CCHT(SZ:000661) Xin Lang Cai Jing·2025-09-16 02:43Group 1 - The core viewpoint of the news is that Changchun High-tech has experienced fluctuations in stock price and trading volume, with a recent decline of 2.01% on September 16, 2023, and a total market capitalization of 50.69 billion yuan [1] - As of June 30, 2023, Changchun High-tech's revenue for the first half of 2023 was 6.603 billion yuan, a year-on-year decrease of 0.54%, while the net profit attributable to shareholders was 983 million yuan, down 42.85% year-on-year [2] - The company has a strong focus on the pharmaceutical industry, with 92.83% of its revenue coming from pharmaceuticals, while real estate and service sectors contribute 6.81% and 0.36% respectively [1][2] Group 2 - Changchun High-tech has a history of dividend payments, with a total of 4.791 billion yuan distributed since its A-share listing, and 3.259 billion yuan in the last three years [3] - The company is categorized under the pharmaceutical and biological industry, specifically in the sub-sector of biological products, and is associated with concepts such as Northeast revitalization and innovative drugs [2] - As of June 30, 2023, the number of shareholders decreased by 12.78% to 109,100, while the average circulating shares per person increased by 14.66% to 3,662 shares [2]